AFP and hepatocellular carcinoma: The serum levels of AFP were higher in patients with HCC in verification group than in healthy donors (402.60±24.09 vs. 14.01±0.84 ng/ml, P<0.0001), however, significant differences were also detected between CHB, LC and HD (246.70±26.42 vs. 14.01±0.84 ng/ml, P<0.0001; 94.65±25.29 vs. 14.01±0.84 ng/ml, P<0.0001, respectively, Figure 1D).